#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4434	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2492	524.3	0	.	n	.	0	C207T	SNP	207	207	C	639	639	T	573	T,C,A	352,151,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4434	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2492	524.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1882	1882	T	687	T,C,G	477,158,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4434	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2492	524.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1616	1616	C	641	C,A,T,G	583,1,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4434	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2492	524.3	0	HET	.	.	.	C451T,G	.	451	451	C	883	883	C	632	C,T,G	288,277,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7222	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4282	505.8	0	.	n	.	0	T695C	SNP	695	695	T	1369	1369	C	580	C,G	510,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7222	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4282	505.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2645	2645	C	654	C	598	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7222	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4282	505.8	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3271	3271	T	654	T,C	575,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7222	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4282	505.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2719	2719	A	705	A	626	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	650	folP	855	855	100.0	folP.l15.c4.ctg.1	1877	103.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1198	1200	AGC	142;143;143	A,G;G;C	127,1;125;127	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1396	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3924	106.6	1	SNP	p	S91F	1	.	.	271	273	TTC	848	850	TTC	124;124;124	T;T;C	115;112;114	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1396	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3924	106.6	1	SNP	p	G95N	0	.	.	283	285	GGC	860	862	GGC	122;122;122	G;G;C	116;109;115	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1396	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3924	106.6	1	SNP	p	D95G	1	.	.	283	285	GGC	860	862	GGC	122;122;122	G;G;C	116;109;115	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	636	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1925	99.0	1	SNP	p	G45D	0	.	.	133	135	GGC	827	829	GGC	187;187;188	G;G;C	174;167;176	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	430	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1348	95.1	0	.	n	.	0	A197.	DEL	197	197	A	728	728	A	174	A	161	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1664	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3627	137.1	1	SNP	p	D86N	0	.	.	256	258	GAC	914	916	GAC	159;158;158	G,A,T;A;C,A	137,1,1;141;142,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1664	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3627	137.1	1	SNP	p	S87R	1	.	.	259	261	CGT	917	919	CGT	159;160;160	C;G,T;T,G	144;143,1;143,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1664	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3627	137.1	1	SNP	p	R87I	0	.	.	259	261	CGT	917	919	CGT	159;160;160	C;G,T;T,G	144;143,1;143,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1664	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3627	137.1	1	SNP	p	R87W	0	.	.	259	261	CGT	917	919	CGT	159;160;160	C;G,T;T,G	144;143,1;143,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1664	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3627	137.1	1	SNP	p	S88P	0	.	.	262	264	TCC	920	922	TCC	160;159;161	T;C;C	147;145;145	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1210	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3328	109.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1887	1889	GGC	154;153;154	G;G;C	131;133;129	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	1128	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2812	120.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1464	1466	GCC	150;149;149	G;C;C,T	134;126;132,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1128	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2812	120.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1467	1469	ATG	146;145;146	A;T;G	133;130;131	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1128	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2812	120.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1479	1481	ACC	143;143;144	A,T;C;C	125,1;127;130	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1128	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2812	120.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1479	1481	ACC	143;143;144	A,T;C;C	125,1;127;130	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1128	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2812	120.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1980	1982	ACC	152;154;154	A,T;C;C,A,G	139,1;134;138,1,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1128	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2812	120.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2034	2036	GCG	164;163;164	G;C;G,T	144;143;145,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1128	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2812	120.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2034	2036	GCG	164;163;164	G;C;G,T	144;143;145,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1128	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2812	120.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2157	2159	GGT	162;162;163	G;G;T	149;144;146	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1128	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2812	120.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2166	2168	AGC	163;163;163	A,C;G;C	144,1;146;150	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1128	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2812	120.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2184	2186	CCG	156;156;151	C;C;G,C	138;142;129,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1538	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3657	126.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1875	1877	CCG	139;141;139	C;C;G	111;122;123	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	824	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2391	103.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	890	890	C	124	C	116	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	150	porB1a	984	305	90.61	porB1a.l15.c4.ctg.1	1562	28.2	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1282	1284	AAT	21;21;21	A;A;T	19;19;19	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	150	porB1a	984	305	90.61	porB1a.l15.c4.ctg.1	1562	28.2	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1285	1287	AAT	21;21;21	A;A;T	19;19;19	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	150	porB1a	984	305	90.61	porB1a.l15.c4.ctg.1	1562	28.2	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1309	1311	GCA	20;20;20	G;C;A	19;18;19	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	150	porB1a	984	305	90.61	porB1a.l15.c4.ctg.1	1562	28.2	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1332	1334	GTA	18;18;18	G;T;A	17;18;18	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	150	porB1a	984	305	90.61	porB1a.l15.c4.ctg.1	1562	28.2	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1341	1341	A	17	A	17	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	868	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	1665	150.6	0	.	p	.	0	G48E	NONSYN	142	144	GGA	537	539	GAA	213;213;213	G,A;A,G;A	187,1;191,1;192	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	868	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	1665	150.6	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1023	1025	AGA	162;161;159	A;G,A;A	151;147,1;146	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	868	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	1665	150.6	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1044	1046	GGT	155;156;155	G,C;G;T	141,1;144;141	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	868	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	1665	150.6	1	SNP	p	G120K	1	.	.	358	360	AAG	753	755	AAG	219;219;219	A;A;G	195;194;192	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	868	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	1665	150.6	1	SNP	p	A121N	1	.	.	361	363	AAC	756	758	AAC	218;217;215	A;A;C	186;191;191	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	868	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	1665	150.6	1	SNP	p	N121D	0	.	.	361	363	AAC	756	758	AAC	218;217;215	A;A;C	186;191;191	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2720	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5345	152.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	446	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1581	84.4	1	SNP	p	V57M	1	.	.	169	171	ATG	793	795	ATG	156;156;156	A;T;G	141;139;141	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
